RecruitingNCT06206603

Epigenetic Regulation of Colorectal Polyps and Cancer

Epigenetic Regulation of Colorectal Polyps and Cancer and Its Traceability in Blood

Sponsor

Region Skane

Enrollment

400 participants

Start Date

Jan 3, 2024

Study Type

OBSERVATIONAL

Summary

The goal of this study is to learn about the epigenetic and genetic regulation (microRNA/mRNA) of colorectal polyps and their evolvement as polyps and to colorectal cancer. Furthermore, the study aims at investigating whether certain epigenetic features, linked to polyps and/or cancer are traceable in blood samples. The main questions the study aims to answer are: 1. Are there specific microRNA/mRNA that are expressed in different types of polyps and cancers and their respective stages? 2. Is microRNA/mRNA expression in polyps and cancer traceable in blood from the same patient? 3. Is the intestinal microbiata correlated with colorectal polyps and cancer and their microRNA/mRNA expression? Type of study: clinical trial Participant population Participants consist of patients undergoing a scheduled colonoscopy where a polyp or cancer is discovered. Healthy controls, with normal colonoscopy findings will be enrolled. Biopsies will be obtained from polyps/cancers and from normal surrounding intestinal mucosa. Biopsies will be obtained from defined intestinal locations from healthy controls. Blood samples will be collected from all participants. Researchers will compare microRNA/mRNA and microbiota in patients with polyps/cancers and their respective stages as well as healthy controls. Comparisons include biopsies and blood samples.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study collects tissue samples from patients undergoing colonoscopy to study how chemical changes on DNA (called epigenetic changes) relate to the development of colorectal polyps and cancer. The goal is to find new markers that can detect cancer risk early. **You may be eligible if...** - You are over 18 years old - You are scheduled for a colonoscopy to examine or remove colorectal polyps **You may NOT be eligible if...** - You have a history of colorectal cancer - You are unable to understand study information or give informed consent Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTIntestinal biopsies

Approximately 6 biopsies (each around 2-3mm in size) are taken from the polyp or cancer, as well as adjacent healthy intestinal mucosa, during a scheduled colonoscopy. For healthy controls, around 6 biopsies are taken from the healthy intestinal mucosa. The intestinal biopsies are frozen at -80 degrees Celsius.

DIAGNOSTIC_TESTBlood sample

A venous blood sample (10ml) will be taken in connection with the colonoscopy. Patients typically receive an intravenous needle for the administration of sedatives and pain-relieving medications during the colonoscopy, so the current blood sample does not cause any additional needle sticks or discomfort for the patient. The blood sample is centrifuged, and the plasma is frozen at -80 degrees Celsius.

Locations(1)

Skane University Hospital, Malmö, section of Surgery

Malmo, Skåne County, Sweden

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06206603